Crystal Wong, MD

Rituximab non-responders may still be amenable to B-cell targeted therapies, such as ofatumumab or obinutuzumab.

In patients with AS, those with a BMI in the overweight or obese range had a lower likelihood of clinical improvement with tumor necrosis factor inhibitor therapy.

The ability of Power Doppler Ultrasound to predict short-term psoriatic arthritis disease flare was investigated in a new study.

Hip osteoarthritis risk may be increased by a higher rate of dairy product consumption.

Predictors for developing ExRA included older age, longer duration of RA, male sex, and positive rheumatoid factor at baseline.

SNB and FNB was more effective in pain relief for patients undergoing TKA.

In a randomized trial that compared the efficacy of yoga, physical therapy, and education for patients with chronic low back pain, yoga was deemed noninferior to PT.

COBRA is a combination therapy regimen for RA that has been shown to be safe and effective in the early stages of RA for improving short- and long-term outcomes.

Our results demonstrate that a significant portion of patients classified as in clinical remission by DAS28 present some imaging findings suggesting disease activity in their clinical dominant foot

Determining which patients are unlikely to respond to therapy early on may help reduce unnecessary treatment and contain costs.